NUR 354 Exam 4 | Questions with 100% Verified Answers | Latest
Update 2026/2027
Question: DM education
Answer:
- pharmacological interventions, nutrition management, patient education and self-
management, and detection and prevention of complications.
- Insulin administration: rotating sites (arm to abdomen), angle of injection (fatter 90
degrees, 45 degrees if unable to pinch fat)
- Family teaching: signs of hyperglycemia and hypoglycemia
Question: DM labs
Answer:
Glucose and A1C
Question: Insulin peak, onset, duration
Answer:
See table 45.1
Question: What should you monitor before and after administration of
insulin
Answer:
Glucose
Question: How do you mix insulins in one syringe?
Answer:
1. Gather supplies
2. Verify orders
3. 6 rights
4. Roll vials to mix
5. Clean the tops with alcohol
6. Put air into NPH insulin (Do not touch medication)
7. Put air into regular insulin and draw up regular insulin
8. Draw up NPH insulin
Question: How do you administer insulin?
Answer:
Subcutaneously, rotate injection sites arm to abdomen.
, Question: What insulins can be mixed?
Answer:
NPH with rapid/short acting insulin (aspart, lispro, glulisine, regular)
Question: What insulins can be administered IV?
Answer:
Insulin R
Question: Side effects of insulin?
Answer:
hypoglycemia (tachycardia, confusion, sweating, and drowsiness), weight gain
Question: metformin side effects
Answer:
nausea, vomiting, abdominal discomfort, metallic taste, diarrhea, and anorexia. headache,
dizziness, agitation, and fatigue. Blackbox: lactic acidosis
Question: metformin education
Answer:
- Extended-release tablets must be swallowed whole and not crushed or chewed.
- Fasting blood glucose levels should be obtained every 3 months, and the dose
adjusted accordingly.
- Discontinue the medication immediately if signs of acidosis are present
Question: metformin labs to monitor
Answer:
glucose
Question: how does metformin work?
Answer:
reduces fasting and postprandial glucose levels
by decreasing the hepatic production of glucose (gluconeogen-esis) and reducing
insulin resistance.
Question: GLP1 receptor agonist
Answer:
Exenatide, liraglutide
Update 2026/2027
Question: DM education
Answer:
- pharmacological interventions, nutrition management, patient education and self-
management, and detection and prevention of complications.
- Insulin administration: rotating sites (arm to abdomen), angle of injection (fatter 90
degrees, 45 degrees if unable to pinch fat)
- Family teaching: signs of hyperglycemia and hypoglycemia
Question: DM labs
Answer:
Glucose and A1C
Question: Insulin peak, onset, duration
Answer:
See table 45.1
Question: What should you monitor before and after administration of
insulin
Answer:
Glucose
Question: How do you mix insulins in one syringe?
Answer:
1. Gather supplies
2. Verify orders
3. 6 rights
4. Roll vials to mix
5. Clean the tops with alcohol
6. Put air into NPH insulin (Do not touch medication)
7. Put air into regular insulin and draw up regular insulin
8. Draw up NPH insulin
Question: How do you administer insulin?
Answer:
Subcutaneously, rotate injection sites arm to abdomen.
, Question: What insulins can be mixed?
Answer:
NPH with rapid/short acting insulin (aspart, lispro, glulisine, regular)
Question: What insulins can be administered IV?
Answer:
Insulin R
Question: Side effects of insulin?
Answer:
hypoglycemia (tachycardia, confusion, sweating, and drowsiness), weight gain
Question: metformin side effects
Answer:
nausea, vomiting, abdominal discomfort, metallic taste, diarrhea, and anorexia. headache,
dizziness, agitation, and fatigue. Blackbox: lactic acidosis
Question: metformin education
Answer:
- Extended-release tablets must be swallowed whole and not crushed or chewed.
- Fasting blood glucose levels should be obtained every 3 months, and the dose
adjusted accordingly.
- Discontinue the medication immediately if signs of acidosis are present
Question: metformin labs to monitor
Answer:
glucose
Question: how does metformin work?
Answer:
reduces fasting and postprandial glucose levels
by decreasing the hepatic production of glucose (gluconeogen-esis) and reducing
insulin resistance.
Question: GLP1 receptor agonist
Answer:
Exenatide, liraglutide
